vTv Therapeutics Inc. Interest Expense Operating
vTv Therapeutics Inc. (VTVT) reported Interest Expense Operating of $6.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOperating · last filed 2026-03-10
- vTv Therapeutics Inc. interest expense operating for the quarter ending 2025-12-31 was $1.00K.
- vTv Therapeutics Inc. interest expense operating for the quarter ending 2025-09-30 was $5.00K.
- vTv Therapeutics Inc. interest expense operating for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- vTv Therapeutics Inc. interest expense operating for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- vTv Therapeutics Inc. interest expense operating for fiscal 2025 was $6.00K.
- vTv Therapeutics Inc. interest expense operating for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- vTv Therapeutics Inc. interest expense operating for fiscal 2023 was $13.00K.
| Period end | Interest Expense Operating 3 month | Interest Expense Operating 6 month | Interest Expense Operating 9 month | Interest Expense Operating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.00K derived: sum of 2 quarters · filed 2026-03-10 | $6.00K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-06 | $5.00K 10-Q · filed 2025-11-06 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.00K derived: sum of 2 quarters · filed 2026-03-10 | $13.00K derived: sum of 3 quarters · filed 2026-03-10 | $13.00K 10-K · filed 2026-03-10 |
| 2023-09-30 | $4.00K 10-Q · filed 2024-11-12 | $6.00K derived: sum of 2 quarters · filed 2024-11-12 | $6.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $2.00K 10-Q · filed 2024-08-08 | $2.00K 10-Q · filed 2024-08-08 |